Ilaris Medication Information
Ilaris® (canakinumab) is a drug used to treat a group of rare genetic autoinflammatory conditions known as cryopyrin-associated periodic syndromes (CAPS). Some of these conditions include familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS). Ilaris works by blocking the action of certain proteins that cause inflammation throughout the body.
This medication is given as an injection just under the skin (subcutaneously) once every eight weeks. To help ensure safe treatment with Ilaris, the medication's safety information should be reviewed before you start using it. This medicine may not be suitable for everyone, so let your healthcare provider know if you are pregnant or breastfeeding, have certain medical conditions (such as hepatitis, HIV, or a weakened immune system), or have any allergies.
(For more information on this medication, click Ilaris. This article tells you what you need to know about potential side effects, dosing guidelines, safety concerns, and more.)